NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹262 Cr | ₹216 Cr | ₹194 Cr | ₹98 Cr | ₹72 Cr |
What is the latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹262 Cr |
Mar2023 | ₹216 Cr |
Mar2022 | ₹194 Cr |
Mar2013 | ₹98 Cr |
Mar2012 | ₹72 Cr |
How is Total Current Liabilities of NATH BIOGENES (INDIA) Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹262 Cr | 21.26 | |
Mar2023 | ₹216 Cr | 11.40 | |
Mar2022 | ₹194 Cr | 98.02 | |
Mar2013 | ₹98 Cr | 36.20 | |
Mar2012 | ₹72 Cr | - |
Compare Total Current Liabilities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹376.3 Cr | 9.4% | 6.2% | -4.6% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹16,842.9 Cr | -5.1% | -12.2% | 71.1% | Stock Analytics | |
KAVERI SEED COMPANY | ₹4,714.1 Cr | 0.7% | 1.5% | 47.5% | Stock Analytics | |
VENKYS (INDIA) | ₹2,471.9 Cr | 2.5% | -2.7% | -13.1% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,705.8 Cr | 12.7% | -1.8% | -21.8% | Stock Analytics | |
TIERRA AGROTECH | ₹416.9 Cr | -0% | 0.8% | -34.1% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | 9.4% |
6.2% |
-4.6% |
SENSEX | 1.1% |
1.1% |
22.2% |
You may also like the below Video Courses